The high cost and complexity of specialty medications often contribute to adherence issues that negatively impact patient outcomes. Increasing adherence requires streamlined access to specialty medications and clear and frequent communication with patients to discuss dosage, frequency, side effects, interactions, and more. Learn how Bausch Health and Omnicell Specialty Pharmacy Services worked together to improve adherence to XIFAXAN, a specialty medication used to treat overt hepatic encephalopathy (OHE), by expediting the prior authorization process and conducting in-depth medication counseling.
Podden och tillhörande omslagsbild på den här sidan tillhör Omnicell. Innehållet i podden är skapat av Omnicell och inte av, eller tillsammans med, Poddtoppen.
